Document is current
Any future updates will be listed below
-
Authors
Anzalone, Nicoletta https://orcid.org/0000-0002-4249-2723
Castellano, Antonella https://orcid.org/0000-0002-4137-9016
Scotti, Roberta
Scandroglio, Anna Mara https://orcid.org/0000-0003-0639-8227
Filippi, Massimo https://orcid.org/0000-0002-5485-0479
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
Tresoldi, Moreno https://orcid.org/0000-0002-1213-6074
Falini, Andrea https://orcid.org/0000-0002-1461-8755
- License Information
-
More Information
Article History
Received: 10 May 2020
Revised: 28 May 2020
Accepted: 30 May 2020
First Online: 6 June 2020
Compliance with ethical standards
:
: M. Filippi is Editor-in-Chief of the Journal of Neurology; received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). None are relevant to this manuscript. The other authors have nothing to disclose.
: The study was approved by the Ethics Committee of IRCCS San Raffaele Scientific Institute, Milan, Italy.
: All patients provided signed informed consent prior to MR imaging. Informed consent was collected from the patients for the inclusion of deidentified clinical data in a scientific publication, in accordance with the Declaration of Helsinki.
Free to read: This content has been made available to all.
